Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. Int. J. Mol. Sci. 2023, 24, 5869

Int J Mol Sci. 2024 Nov 14;25(22):12225. doi: 10.3390/ijms252212225.

E Titmuss¹, K Milne², M R Jones¹, T Ng³, J T Topham⁴, S D Brown¹, D F Schaeffer⁴, S Kalloger³, D Wilson⁵, R D Corbett¹, L M Williamson¹, K Mungall¹, A J Mungall¹, R A Holt^{1

6}, B H Nelson^{2

6}, S J M Jones¹, J Laskin⁵, H J Lim⁵, M A Marra^{1

6}

¹ Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada.
² Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.
³ Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
⁴ Pancreas Centre BC, Vancouver, BC V5Z 1G1, Canada.
⁵ Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
⁶ Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada.

Abstract

The journal's Editorial Office and Editorial Board are jointly issuing a resolution and removal of the Journal Notice linked to this article [...].